
Enzem Pharmaceuticals Private Limited
Pharmaceutical company specializing in trading of medical products.
Pharmaceutical company specializing in trading of medical products.
Enzem Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 2014 and has a history of Ten years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.00 M.
Kolakunte Ramamurthy and Suma Ramamurthy serve as directors at the Company.
Bangaluru, Karnataka, India
+91-XXXXXXXXXX
-
U51101KA2014PTC075312
075312
Private Limited Indian Non-Government Company
10 Jul 2014
30 Sep 2024
31 Mar 2024
Unlisted
Roc Bangalore
Enzem Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Multivitamin Tablets & Capsules, Antioxidant Capsule, Vitamin Tablets & Capsules, Vitamin C Tablets & Capsules, Allopathic Cough Syrup, Dextromethorphan Cough Syrup.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kolakunte Ramamurthy ![]() | Director | 10-Jul-2014 | Current |
Suma Ramamurthy ![]() | Director | 20-Feb-2018 | Current |
Enzem Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.8% increase. The company also saw a substantial fall in profitability, with a 18.33% decrease in profit. The company's net worth moved up by a moderate rise of 8.54%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Enzem Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹1.00 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
13 Feb 2020 | State Bank Of India | ₹1.00 M | Open |
Unlock and access historical data on people associated with Enzem Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Enzem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enzem Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Enzem Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Enzem Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
A charge with State Bank Of India amounted to Rs. 1.00 M with Charge ID 100326371 was registered on 13 Feb 2020.
Suma Ramamurthy was appointed as a Director was appointed as a Director on 20 Feb 2018 & has been associated with this company since 7 years 10 days .
Kolakunte Satyanarayana Ramamurthy was appointed as a Director was appointed as a Director on 10 Jul 2014 & has been associated with this company since 10 years 7 months .
Enzem Pharmaceuticals Private Limited was registered on 10 Jul 2014 with Roc Bangalore & aged 10 years 7 months as per MCA records.
Enzem Pharmaceuticals Private Limited was incorporated on 10 Jul 2014.
The authorized share capital of Enzem Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.
Currently 2 directors are associated with Enzem Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Enzem Pharmaceuticals Private Limited is 20 Mithila Ground Floor Phase I Royal Elite Residency Cv Raman Road Kodipalya India, Bangalore South, Karnataka, 560060.
The corporate identification number (CIN) of Enzem Pharmaceuticals Private Limited is U51101KA2014PTC075312 and the company number is 075312 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Enzem Pharmaceuticals Private Limited has risen by 3.80%.
The financial reports for the fiscal year 2022 indicates that The net worth of Enzem Pharmaceuticals Private Limited has experienced an upsurge of 8.54%.
As per the financial statements for fiscal Year 2022, The total open charges for Enzem Pharmaceuticals Private Limited amount to ₹ 1.00 M.
The most recent Balance Sheet for Enzem Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
PG
DP
HN
MR
SB